DOI:
10.1055/s-00000014
Erfahrungsheilkunde
LinksClose Window
References
Blauwhoff-Buskermolen S, Versteeg K, de van der Schueren M. et al.
Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer.
J Clin Oncol 2016;
34: 1339-1344
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.